About Codex DNA
Synthetic DNA on demand
Our mission is to apply our breakthroughs in automation solutions for DNA, RNA, and protein synthesis to enable customers to program and "write" synthetic biology that creates sustainable healthcare and technology solutions for some of humanity’s biggest challenges.
Codex DNA products are radically transforming rapid demand and response workflows by consolidating supply chains and enabling global distributed manufacturing for both discovery and clinical applications.
Our gene synthesis portfolio reduces the turnaround time for synthesizing workflows from weeks and months to days and hours, and includes the BioXp™ system, BioXp™ biofoundry services, Gibson Assembly® reagents, and Vmax™ chemically competent cells.
In addition to automating, accelerating, and optimizing DNA design, synthesis, cloning and amplification, Codex DNA and the BioXp™ system ensure your designs stay in your hands, marrying speed and security for innovators in drug discovery, vaccine development, precision medicine, and beyond.
Co-founded by Dan Gibson — the creator of the industry-standard Gibson Assembly® methodology — Codex DNA is attempting nothing less than building biology and changing everything.
Codex DNA is committed to best practices in biosecurity and is a member of the International Gene Synthesis Consortium. We support researchers and the synthetic biology community with the responsible synthesis of genes for discovering and creating new medicines, diagnostic tests, agricultural biotechnology products, industrial chemicals, and other beneficial applications.